"How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From " by Silvio E Inzucchi, Bernard Zinman et al.
 

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.

Document Type

Journal Article

Publication Date

12-4-2017

Journal

Diabetes Care

Volume

42

Issue

2

Inclusive Pages

356-363

DOI

10.2337/dc17-1096

Peer Reviewed

1

Link to Full Text
Find in your library

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 578
    • Patent Family Citations: 1
    • Policy Citations: 2
    • Clinical Citations: 1
  • Usage
    • Abstract Views: 13
  • Captures
    • Readers: 397
  • Mentions
    • News Mentions: 1
see details

Share

COinS